Dengue patients at greater risk of acute cholecystitis and acute pancreatitis during first month

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-06-28 14:30 GMT   |   Update On 2023-06-29 15:05 GMT

Original research published in Infectious Diseases and Therapy has concluded that dengue patients have an increased risk of acute cholecystitis and acute pancreatitis within the first 30 days postinfection than those without dengue. The researchers found no greater risk of acute appendicitis in these patients.

This study, “Risks of Acute Cholecystitis, Acute Pancreatitis, and Acute Appendicitis in Patients with Dengue Fever: A Population-Based Cohort Study in Taiwan”, is led by Dr Hsin-I Shih and colleagues.

Advertisement

Previous research has well-documented acute cholecystitis, acute pancreatitis, and acute appendicitis following dengue virus infections. There needs to be more data from large-scale studies determining the post-dengue risk of acute abdominal conditions.

The patients included had laboratory-confirmed dengue from 2002 to 2015 in Taiwan. The key results of the study are:

  • Sixty-five thousand six hundred ninety-four individuals with dengue, and 262,776 were without dengue.
  • Within the first 30 days of postinfection, there was an increased risk of acute cholecystitis and acute pancreatitis in dengue patients, with incident rates of 18.79 and 5.27 per 10,000
  • After this period, there was no increased risk.
  • There was no increased risk of acute appendicitis among patients with acute dengue infection.

Concluding further, they said, This study was the first large epidemiological study that has shown significantly increased risk of acute cholecystitis and pancreatitis among dengue patients during the acute phase of dengue infection.

Identifying acute cholecystitis and pancreatitis in dengue patients early is vital to prevent complications.

Study strengths were a large number of patients, no selection bias, and a reduced chance of false-positive findings.

The limitations were misclassification, non-availability of detailed medical records, etc.

Further reading:

https://link.springer.com/article/10.1007/s40121-023-00821-1


Tags:    
Article Source : Infectious Diseases and Therapy

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News